PB0316 Bortezomib for the Treatment of Multi-Refractory Immune-Mediated Thrombotic Thrombocytopenic Purpura: An Italian Multicenter Survey
Research and Practice in Thrombosis and Haemostasis(2023)
关键词
thrombotic thrombocytopenic purpura,pb0316 bortezomib,treatment,multi-refractory,immune-mediated
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要